The Rising Influence of Rising Affluence

[jbog]

The new proposed TPP agreement:

The United States and Australia negotiated a compromise on the minimum period of protection to the rights for data used to make biologic drugs. Companies such as Pfizer Inc, Roche Group's Genentech and Japan's Takeda Pharmaceutical Co could be affected.
Negotiators agreed on terms short of what the United States had sought. Under the deal, countries would give drugmakers at least five years of exclusive access to the clinical data used to win approval for new drugs. An additional several years of regulatory review would likely mean drug companies would have an effective monopoly for about eight years before facing lower-cost, generic competition, officials said.

Looks like the U.S. middle class have been sold out once again.


http://www.aol.com/article/2015/10/05/historic-pacific-trade-deal-faces-skeptics-in-congress/21245186/?icid=maing-grid7%7Cmain5%7Cdl2%7Csec1_lnk3%26pLid%3D-1950435301